TARSUS PHARMACEUTICALS INC (TARS) Stock Earnings & Estimates
NASDAQ:TARS - US87650L1035 - Common Stock
58.85 USD
+2.24 (+3.96%)
58.75 USD
-0.1 (-0.17%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 25.82M -54.73% | 17.447M -32.43% | 182.953M 948.62% | 60.869B 33,170.29% | 620.1M -98.98% | 837.48M 35.06% | 897.59M 7.18% | 1.04B 15.87% | 1.161B 11.63% | 1.354B 16.62% | 1.466B 8.27% | |
| EBITDA YoY % growth | -62.38M -426.41% | -142.281M -128.09% | -119.344M 16.12% | -62.425M 47.69% | 89.074M 242.69% | 228.55M 156.58% | 91.912M -59.78% | 92.381M 0.51% | 92.84M 0.50% | N/A | N/A | |
| EBIT YoY % growth | -62.71M -415.71% | -143.158M -128.29% | -120.569M 15.78% | -63.216M 47.57% | 80.885M 227.95% | 195.64M 141.87% | 272.85M 39.47% | 396.93M 45.48% | 507.1M 27.76% | 685.11M 35.10% | 787.35M 14.92% | |
| Operating Margin | -242.87% | -820.53% | -65.90% | -0.10% | 13.04% | 23.36% | 30.40% | 38.17% | 43.68% | 50.60% | 53.71% | |
| EPS YoY % growth | -2.55 -275.00% | -4.64 -81.96% | -3.10 33.19% | -1.40 54.78% | 1.69 220.59% | 4.32 155.64% | 0.31 -92.92% | 1.09 256.67% | 2.92 167.29% | 5.07 73.78% | 6.55 29.18% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 41.20% | -0.03 95.75% | -0.05 92.03% | 0.23 148.88% | 0.41 213.74% | 0.83 3,340.00% | 0.78 1,620.00% | 1.12 378.26% | 1.32 222.50% | 1.66 101.23% |
| Revenue Q2Q % growth | 115.31M 139.64% | 134.3M 102.23% | 143M 82.55% | 165.75M 61.46% | 178.91M 55.16% | 200.23M 49.09% | 200.34M 40.10% | 222.59M 34.29% | 238.32M 33.21% | 257.85M 28.78% |
| EBITDA Q2Q % growth | -27.54M -13.01% | -18.36M 20.85% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -15.402M 38.79% | -1.895M 92.24% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.48 45.45% | -0.41 | -0.07 | -17.77% |
| Q1 2025 Q2Q % growth | -0.64 36.63% | -0.75 | 0.11 | 14.11% |
| Q4 2024 Q2Q % growth | -0.60 54.20% | -0.76 | 0.16 | 20.78% |
| Q3 2024 Q2Q % growth | -0.61 52.34% | -0.99 | 0.38 | 38.50% |
| Q2 2024 Q2Q % growth | -0.88 24.79% | -0.94 | 0.06 | 6.62% |
| Q1 2024 Q2Q % growth | -1.01 -14.77% | -1.23 | 0.22 | 17.81% |
| Q4 2023 Q2Q % growth | -1.31 -167.35% | -1.39 | 0.08 | 5.75% |
| Q3 2023 Q2Q % growth | -1.28 -52.38% | -1.39 | 0.11 | 8.10% |
| Q2 2023 Q2Q % growth | -1.17 -387.50% | -1.10 | -0.07 | -6.36% |
| Q1 2023 Q2Q % growth | -0.88 10.20% | -0.96 | 0.08 | 8.70% |
| Q4 2022 Q2Q % growth | -0.49 31.94% | -0.70 | 0.21 | 30.38% |
| Q3 2022 Q2Q % growth | -0.84 -10.53% | -0.99 | 0.15 | 15.35% |
| Q2 2022 Q2Q % growth | -0.24 -172.73% | -0.60 | 0.36 | 60.15% |
| Q1 2022 Q2Q % growth | -0.98 -308.51% | -0.94 | -0.04 | -4.68% |
| Q4 2021 Q2Q % growth | -0.72 -5.88% | -0.74 | 0.02 | 2.98% |
| Q3 2021 Q2Q % growth | -0.76 79.51% | -0.44 | -0.32 | -71.68% |
| Q2 2021 Q2Q % growth | 0.33 | -0.49 | 0.82 | 167.87% |
| Q1 2021 Q2Q % growth | 0.47 | -0.65 | 1.12 | 172.00% |
| Q4 2020 Q2Q % growth | -0.68 | -0.67 | -0.01 | -1.01% |
| Q3 2020 Q2Q % growth | -3.71 | -0.54 | -3.17 | -586.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 102.66M 151.54% | 97.596M | 5.064M | 5.19% |
| Q1 2025 Q2Q % growth | 78.335M 183.68% | 73.917M | 4.418M | 5.98% |
| Q4 2024 Q2Q % growth | 66.408M 407.86% | 59.494M | 6.914M | 11.62% |
| Q3 2024 Q2Q % growth | 48.118M 2,471.78% | 44.306M | 3.812M | 8.60% |
| Q2 2024 Q2Q % growth | 40.813M | 32.297M | 8.516M | 26.37% |
| Q1 2024 Q2Q % growth | 27.614M 1,004.56% | 17.805M | 9.809M | 55.09% |
| Q4 2023 Q2Q % growth | 13.076M 30.76% | 5.778M | 7.298M | 126.31% |
| Q3 2023 Q2Q % growth | 1.871M | 407.796K | 1.463M | 358.81% |
| Q2 2023 Q2Q % growth | -100.00% | 1.795M | -1.795M | -100.00% |
| Q1 2023 Q2Q % growth | 2.5M 362.96% | 3.188M | -688K | -21.58% |
| Q4 2022 Q2Q % growth | 10M 2,841.18% | 10.2M | -200K | -1.96% |
| Q3 2022 Q2Q % growth | -100.00% | 2.975M | -2.975M | -100.00% |
| Q2 2022 Q2Q % growth | 15.28M -30.61% | 13.26M | 2.02M | 15.23% |
| Q1 2022 Q2Q % growth | 540K -98.38% | 2.244M | -1.704M | -75.94% |
| Q4 2021 Q2Q % growth | 340K | 6.204M | -5.864M | -94.52% |
| Q3 2021 Q2Q % growth | 1.24M | 5.44M | -4.2M | -77.21% |
| Q2 2021 Q2Q % growth | 22.02M | 4.624M | 17.396M | 376.21% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -26.18% | 16.55% | -15.86% | -13.45% |
| Revenue | 8% | 26.13% | 14823.3% | 15051% |